Logo image of QRO.CA

QUADRO RESOURCES LTD (QRO.CA) Stock Fundamental Analysis

TSX-V:QRO - TSX Venture Exchange - CA74733P3016 - Common Stock - Currency: CAD

0.035  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to QRO. QRO was compared to 802 industry peers in the Metals & Mining industry. The financial health of QRO is average, but there are quite some concerns on its profitability. QRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

QRO had negative earnings in the past year.
QRO had a negative operating cash flow in the past year.
QRO.CA Yearly Net Income VS EBIT VS OCF VS FCFQRO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -200K -400K -600K -800K -1M

1.2 Ratios

QRO's Return On Assets of -22.24% is in line compared to the rest of the industry. QRO outperforms 47.38% of its industry peers.
QRO has a Return On Equity (-23.62%) which is in line with its industry peers.
Industry RankSector Rank
ROA -22.24%
ROE -23.62%
ROIC N/A
ROA(3y)-26.24%
ROA(5y)N/A
ROE(3y)-27.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QRO.CA Yearly ROA, ROE, ROICQRO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

QRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QRO.CA Yearly Profit, Operating, Gross MarginsQRO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for QRO remains at a similar level compared to 1 year ago.
There is no outstanding debt for QRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QRO.CA Yearly Shares OutstandingQRO.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
QRO.CA Yearly Total Debt VS Total AssetsQRO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

Based on the Altman-Z score of -4.62, we must say that QRO is in the distress zone and has some risk of bankruptcy.
QRO has a Altman-Z score of -4.62. This is in the lower half of the industry: QRO underperforms 65.09% of its industry peers.
There is no outstanding debt for QRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.62
ROIC/WACCN/A
WACCN/A
QRO.CA Yearly LT Debt VS Equity VS FCFQRO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 1M -1M 2M 3M

2.3 Liquidity

A Current Ratio of 1.04 indicates that QRO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.04, QRO is in line with its industry, outperforming 42.89% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that QRO should not have too much problems paying its short term obligations.
QRO has a Quick ratio of 1.04. This is comparable to the rest of the industry: QRO outperforms 45.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
QRO.CA Yearly Current Assets VS Current LiabilitesQRO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.32% over the past year.
EPS 1Y (TTM)15.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QRO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QRO.CA Price Earnings VS Forward Price EarningsQRO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QRO.CA Per share dataQRO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUADRO RESOURCES LTD

TSX-V:QRO (5/9/2025, 7:00:00 PM)

0.035

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.41%
Ins Owner ChangeN/A
Market Cap997.85K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB 0.48
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.24%
ROE -23.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.24%
ROA(5y)N/A
ROE(3y)-27.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z -4.62
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.82%
OCF growth 3YN/A
OCF growth 5YN/A